PMID: 6020008Apr 1, 1967Paper

Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12

The Journal of Experimental Medicine
H O SjögrenJ Ankerst

Abstract

A specific isograft resistance against three different mouse adeno 12 sarcomas was demonstrated in mice treated with four to eight doses of viable or X-ray-killed adeno 12 mouse tumors. Whole-body X-ray irradiation with 350 R 24 hr previous to the test challenge did not abolish the resistance, indicating that it was due to a true anamnestic immune reaction. This was further proven by the finding that similar treatment with tumors of other origin did not induce any immunity, nor did the treatment with adeno 12 tumor material induce any immunity against two neoplasms of Schmidt-Ruppin-Rous viral origin. The previous report by Trentin et al. (17) that adeno 12 infection leads to a specific transplantation immunity was fully confirmed. When the specificity of this virus-induced immunity was studied it was discovered that besides adeno virus type 12, type 7 and probably type 18 also gave the same type of resistance while adenovirus type 5 did not. A contamination of the adeno 7-infected mice with adeno type 12 was excluded by testing pooled sera from these animals for anti-adeno 12 CF or HI antibodies.

References

Aug 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·R J HuebnerK Schell
Apr 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·J J Trentin, E Bryan
Apr 1, 1966·Journal of Molecular Biology·T L Benjamin
Feb 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·J D LevinthalJ J Trentin
Jun 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·K Fujinaga, M Green
Sep 14, 1962·Science·J J TRENTING TAYLOR
Aug 1, 1963·Proceedings of the National Academy of Sciences of the United States of America·R J HUEBNERW T LANE
Jan 3, 1964·Science·Y YABEJ J TRENTIN
Dec 1, 1963·Proceedings of the National Academy of Sciences of the United States of America·P H BLACKR J HUEBNER
Jan 1, 1964·Annual Review of Medicine·L J OLD, E A BOYSE
Mar 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·R J HUEBNERH C TURNER
May 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·R J HUEBNERH C TURNER
Jul 1, 1964·Proceedings of the Society for Experimental Biology and Medicine·I KITAMURAJ J TRENTIN
Aug 1, 1964·The Journal of Experimental Medicine·J H POPE, W P ROWE
Oct 1, 1964·The Journal of Experimental Medicine·J H POPE, W P ROWE
Jan 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·N J SCHMIDTE H LENNETTE
Jan 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·M D HOGGANR J HUEBNER
Aug 1, 1965·The Journal of Experimental Medicine·N JONSSON, H O SJOEGREN
Jun 1, 1965·The Journal of Experimental Medicine·L D BERMAN, W P ROWE

❮ Previous
Next ❯

Citations

Apr 1, 1974·Virology·M Ishibashi, J V Maizel
Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S KvistP A Peterson
Jun 1, 1967·The Journal of Experimental Medicine·L D Berman
Jan 1, 1972·Journal of Clinical Pathology. Supplement (Royal College of Pathologists)·H G Pereira
Dec 30, 1998·Leukemia & Lymphoma·H G Drexler, J Minowada
Jul 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R C Rees, C W Potter
May 1, 1968·Acta Pathologica Japonica·T Ito
Jan 15, 1969·International Journal of Cancer. Journal International Du Cancer·H O Sjögren, D Motet
Jan 1, 1969·Archiv für die gesamte Virusforschung·C W PotterJ S Oxford
Jan 1, 1974·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·N SeemayerG Seemayer
Jul 15, 1970·International Journal of Cancer. Journal International Du Cancer·J Vasconcelos-Costa
May 15, 1969·International Journal of Cancer. Journal International Du Cancer·J Ankerst, H O Sjögren
Jul 16, 1976·Biochimica Et Biophysica Acta·F Rapp, D Westmoreland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.